163 related articles for article (PubMed ID: 23988457)
41. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling.
Li C; Xin H; Shi Y; Mu J
Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070
[TBL] [Abstract][Full Text] [Related]
42. Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis.
Liu N; Wang C; Wang L; Gao L; Cheng H; Tang G; Hu X; Wang J
Int J Mol Med; 2016 Jun; 37(6):1686-96. PubMed ID: 27082972
[TBL] [Abstract][Full Text] [Related]
43. PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia.
Pashaiefar H; Yaghmaie M; Tavakkoly-Bazzaz J; Ghaffari SH; Alimoghaddam K; Momeny M; Izadi P; Izadifard M; Kasaeian A; Ghavamzadeh A
Genet Test Mol Biomarkers; 2018 Jun; 22(6):343-349. PubMed ID: 29812960
[TBL] [Abstract][Full Text] [Related]
44. Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia.
Wang H; Lindsey S; Konieczna I; Bei L; Horvath E; Huang W; Saberwal G; Eklund EA
J Biol Chem; 2009 Jan; 284(4):2549-67. PubMed ID: 19022774
[TBL] [Abstract][Full Text] [Related]
45. Clinical significance of the TNF-α receptors, TNFRSF2 and TNFRSF9, on cell migration molecules Fascin-1 and Versican in acute leukemia.
El Kramani N; Elsherbiny NM; El-Gayar AM; Ebrahim MA; Al-Gayyar MMH
Cytokine; 2018 Nov; 111():523-529. PubMed ID: 29861382
[TBL] [Abstract][Full Text] [Related]
46. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia.
Wiley JS; Jones SP; Sawyer WH; Paterson AR
J Clin Invest; 1982 Feb; 69(2):479-89. PubMed ID: 6948829
[TBL] [Abstract][Full Text] [Related]
47. Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.
Papaioannou D; Shen C; Nicolet D; McNeil B; Bill M; Karunasiri M; Burke MH; Ozer HG; Yilmaz SA; Zitzer N; Behbehani GK; Oakes CC; Steiner DJ; Marcucci G; Powell BL; Kolitz JE; Carter TH; Wang ES; Mrózek K; Croce CM; Caligiuri MA; Bloomfield CD; Garzon R; Dorrance AM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4641-E4647. PubMed ID: 28533390
[TBL] [Abstract][Full Text] [Related]
48. miR‑1271‑5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2.
Chen X; Yang S; Zeng J; Chen M
Mol Med Rep; 2019 Jan; 19(1):508-514. PubMed ID: 30483794
[TBL] [Abstract][Full Text] [Related]
49. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
[TBL] [Abstract][Full Text] [Related]
50. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
[TBL] [Abstract][Full Text] [Related]
51. Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity.
Grønningsæter IS; Reikvam H; Aasebø E; Bartaula-Brevik S; Tvedt TH; Bruserud Ø; Hatfield KJ
Cells; 2020 May; 9(5):. PubMed ID: 32392896
[TBL] [Abstract][Full Text] [Related]
52. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.
Radujkovic A; Dietrich S; Andrulis M; Benner A; Longerich T; Pellagatti A; Nanda K; Giese T; Germing U; Baldus S; Boultwood J; Ho AD; Dreger P; Luft T
Int J Cancer; 2016 Sep; 139(6):1402-13. PubMed ID: 27170453
[TBL] [Abstract][Full Text] [Related]
53. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
54. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
55. [Expression and effect of neuropilin-1 in acute myeloid leukemic cells].
Lu L; Zhang L; Xiao ZJ; Lu SH; Wang GS; Yang RC; Han ZC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1150-5. PubMed ID: 18088455
[TBL] [Abstract][Full Text] [Related]
56. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Zhao Y; Zhang T; Zhao Y; Zhou J
Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
[TBL] [Abstract][Full Text] [Related]
57. Ceramide Analogue SACLAC Modulates Sphingolipid Levels and
Pearson JM; Tan SF; Sharma A; Annageldiyev C; Fox TE; Abad JL; Fabrias G; Desai D; Amin S; Wang HG; Cabot MC; Claxton DF; Kester M; Feith DJ; Loughran TP
Mol Cancer Res; 2020 Mar; 18(3):352-363. PubMed ID: 31744877
[TBL] [Abstract][Full Text] [Related]
58. BH3 mimetic ABT-737 induces apoptosis in CD34
Rao J; Li F; Zhang RY; Zhou HH; Chen GA
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e144-e152. PubMed ID: 26552712
[TBL] [Abstract][Full Text] [Related]
59. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy.
Wetzler M; Baer MR; Bernstein SH; Blumenson L; Stewart C; Barcos M; Mrózek K; Block AW; Herzig GP; Bloomfield CD
J Clin Oncol; 1997 Jun; 15(6):2262-8. PubMed ID: 9196139
[TBL] [Abstract][Full Text] [Related]
60. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]